PMID- 20412491 OWN - NLM STAT- MEDLINE DCOM- 20100720 LR - 20110505 IS - 1747-0803 (Electronic) IS - 1747-079X (Linking) VI - 5 IP - 2 DP - 2010 Mar-Apr TI - Discontinuous pulmonary arteries do not preclude good Fontan outcomes. PG - 168-73 LID - 10.1111/j.1747-0803.2009.00334.x [doi] AB - OBJECTIVE: Discontinuous pulmonary arteries are believed to portend poor outcomes for a single ventricle palliation leading to Fontan's operation. This is a single institutional review of patients with single ventricle and discontinuous pulmonary arteries who underwent pulmonary artery centralization as part of staged surgical palliation. DESIGN: The study is a retrospective case series. PATIENTS: From November 1997 to December 2005, 12 centralization procedures were performed on 12 single ventricle patients with discontinuous pulmonary arteries. The diagnoses at surgery were as follows: heterotaxy 67%, pulmonary atresia 75%, a single morphologic right ventricle 58%, a single morphologic left ventricle 33%, and functional single ventricle with atrial situs inversus 8%. OUTCOME MEASURES: The outcome was assessed by hospital survival, actuarial survival, and New York Heart Association (NYHA) classification at follow-up. RESULTS: The overall actuarial survival following centralization is 100% (95% confidence interval = 0.698 to 1). Seventy-five percent of the patients have undergone a Fontan procedure. Median McGoon ratio pre-Fontan = 1.65 (range: 1-2.1). Median follow-up after Fontan = 4.4 years (range: 1.2-9 years). Overall actuarial survival following Fontan is 100% (95% confidence interval = 0.428-0.911). Following the Fontan, there have been no thromboembolic complications, protein-losing enteropathy, nor Fontan takedowns. One hundred percent of the Fontan patients are NYHA class I. CONCLUSIONS: This experience indicates that a resuscitative strategy for discontinuous pulmonary arteries can result in good outcomes after the Fontan procedure. The presence of discontinuous pulmonary arteries in patients with single ventricle physiology should not preclude a management strategy with the goal of Fontan candidacy. FAU - Randall, Alyssa AU - Randall A AD - Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA. randall@bcm.edu FAU - Carberry, Kathleen AU - Carberry K FAU - Fraser, Charles D Jr AU - Fraser CD Jr LA - eng PT - Journal Article PL - United States TA - Congenit Heart Dis JT - Congenital heart disease JID - 101256510 SB - IM MH - Child MH - Child, Preschool MH - Female MH - *Fontan Procedure/adverse effects MH - Heart Defects, Congenital/physiopathology/*surgery MH - Heart Ventricles/abnormalities MH - Hemodynamics MH - Humans MH - Infant MH - Infant, Newborn MH - Male MH - Palliative Care MH - Postoperative Complications MH - Pulmonary Artery/*abnormalities MH - Retreatment MH - Treatment Outcome EDAT- 2010/04/24 06:00 MHDA- 2010/07/21 06:00 CRDT- 2010/04/24 06:00 PHST- 2010/04/24 06:00 [entrez] PHST- 2010/04/24 06:00 [pubmed] PHST- 2010/07/21 06:00 [medline] AID - CHD334 [pii] AID - 10.1111/j.1747-0803.2009.00334.x [doi] PST - ppublish SO - Congenit Heart Dis. 2010 Mar-Apr;5(2):168-73. doi: 10.1111/j.1747-0803.2009.00334.x.